Related Experiment Video

Updated: Dec 20, 2025

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.4K

RAC1 as a Therapeutic Target in Malignant Melanoma

Alexa C Cannon1, Cristina Uribe-Alvarez2, Jonathan Chernoff2

  • 1Drexel University College of Medicine, 245 N 15th Street, Philadelphia, PA 19102, USA.

Trends in Cancer
|May 28, 2020
PubMed

Insights

Mutations in RAC1 signaling proteins drive cancer by altering cell growth and movement. This review highlights RAC1

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Small GTPases, including RAS and RHO families, are key signaling proteins implicated in oncogenesis.
  • Activating mutations in RAS family genes (KRAS, NRAS, HRAS) are common in various cancers.
  • RHO family gene mutations, particularly in RAC1 and RHOA, are recently identified drivers in specific malignancies.

Purpose of the Study:

  • To review the role of RAC1 signaling in malignant melanoma.
  • To emphasize recent advances in understanding RAC1's oncogenic functions in melanoma.
  • To explore potential therapeutic strategies for RAC1-mutant melanoma.

Main Methods:

  • Review of recent scientific literature focusing on RAC1 signaling pathways.
  • Analysis of cancer genome-sequencing data identifying RAC1 mutations.
  • Examination of studies detailing the effects of RAC1 on melanocyte biology.

Main Results:

  • RAC1 signaling, when activated by mutation, promotes oncogenic processes.
  • RAC1 mutations are increasingly detected in specific cancer types, notably melanoma.
  • Altered RAC1 signaling impacts melanocyte proliferation and motility, contributing to melanoma progression.

Conclusions:

  • RAC1 is a significant oncoprotein in malignant melanoma.
  • Understanding RAC1's role in melanoma pathogenesis opens avenues for targeted therapies.
  • Targeting RAC1 signaling may offer new therapeutic options for patients with RAC1-mutant melanoma.
Keywords:
cancer therapeuticsdriver mutationseffectorsfast-cyclingmalignant melanomasignal transductionsmall GTPases

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.7K
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.3K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.0K